Standout Papers

Effects of Dalcetrapib in Patients with a Recent Acute Coron... 2004 2026 2011 2018 1.4k
  1. Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome (2012)
    Gregory G. Schwartz, Anders Olsson et al. New England Journal of Medicine
  2. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (2007)
    Jeffrey L. Anderson, Cynthia D. Adams et al. Circulation
  3. Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction (2004)
    Kevin A. Bybee, Tomáš Kára et al. Annals of Internal Medicine
  4. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol (2020)
    Kausik K. Ray, R. Scott Wright et al. New England Journal of Medicine
  5. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update) (2012)
    Hani Jneid, Jeffrey L. Anderson et al. Circulation
  6. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol (2017)
    Kausik K. Ray, Ulf Landmesser et al. New England Journal of Medicine
  7. 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (2013)
    Jeffrey L. Anderson, Cynthia D. Adams et al. Journal of the American College of Cardiology
  8. Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia (2020)
    Frederick J. Raal, David Kallend et al. New England Journal of Medicine
  9. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update) (2012)
    Hani Jneid, Jeffrey L. Anderson et al. Journal of the American College of Cardiology
  10. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (2011)
    R. Scott Wright, Jeffrey L. Anderson et al. Journal of the American College of Cardiology
  11. Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial (2023)
    Kausik K. Ray, Frank L.J. Visseren et al. The Lancet Diabetes & Endocrinology
  12. Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis (2021)
    R. Scott Wright, Kausik K. Ray et al. Journal of the American College of Cardiology
  13. Inclisiran and cardiovascular events: a patient-level analysis of phase III trials (2022)
    Kausik K. Ray, Frederick J. Raal et al. European Heart Journal

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 86 standout
Sub-graph 1 of 17

Citing Papers

Durable and efficient gene silencing in vivo by hit-and-run epigenome editing
2024 StandoutNature
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
3 intermediate papers

Works of R. Scott Wright being referenced

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
2020 Standout
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
2017 Standout

Author Peers

Author Last Decade Papers Cites
R. Scott Wright 8491 6304 3120 120 14.4k
Felicita Andreotti 9856 5672 2562 178 14.8k
Keaven M. Anderson 7366 4187 1708 115 14.1k
Christian Spaulding 5200 7398 1758 107 11.5k
John D. Rutherford 9727 6369 2184 103 16.2k
Allen J. Taylor 7426 4964 5324 221 16.1k
David D. Waters 10571 8930 5258 336 21.9k
Joseph Yeboah 6802 3164 2189 130 13.0k
José López‐Sendón 9674 3989 1665 262 13.2k
Bariş Gencer 6318 3600 2175 184 9.6k
Allan M. Skene 9882 6466 1255 34 13.8k

All Works

Loading papers...

Rankless by CCL
2026